Many dietary isothiocyanates (ITCs
Introduction
It is widely accepted that induction of Phase 2 detoxification enzymes [e.g. quinone reductase (QR) and glutathione transferases (GSTs)] and elevation of glutathione (GSH) are a major strategy for protecting cells against a variety of endogenous and exogenous toxic components, such as reactive oxygen species and chemical carcinogens (1, 2) . Cellular Phase 2 enzymes and GSH levels can be elevated by an array of chemically diverse compounds. Studies from a number of laboratories including our own have shown that many isothiocyanates (ITCs) are effective inducers (3) (4) (5) . These compounds and their precursor glucosinolates are broadly distributed in edible plants (6, 7) , and thus are of considerable interest as possible dietary protectors against carcinogens. Indeed, many ITCs have displayed potent activity in blocking chemical carcinogenesis in several animal models (4, 8, 9) .
In a previous study, we showed that ITCs are rapidly accumulated in many cell lines, with intracellular levels reaching the millimolar range (10) . We found that ITCs were accumulated as dithiocarbamates (DTC) derived from conjugation with intracellular GSH and that cellular GSH content appeared to be the factor determining the extent of accumulation (11, 12) . Of particular interest to us was that the total intracellular accumulation levels (area under timeconcentration curve; AUC) of nine ITCs differing considerably in chemical structure, not the peak accumulation levels, correlated with their ability to induce Phase 2 enzymes (GST and QR) (10) . Thus the possibility was raised that the intracellular AUCs of these compounds might provide a suitable marker for determining their inducer activity and anticarcinogenic potential. Because this phenomenon had only been shown in Hepa 1c1c7 cells, we needed to verify the utility and reliability of intracellular AUCs as markers of ITC inducer activity in other cell lines and to determine whether we could increase the inducer activity of a weaker ITC by increasing its intracellular AUC through multiple dosing of the compound. Much evidence indicates that transcriptional activation of Phase 2 enzyme genes is primarily mediated by antioxidant responsive element (ARE) or electrophile responsive element (EpRE) located on the upstream region of the genes (13) (14) (15) (16) . In order to determine whether ARE/EpRE also play a role in AUCdependent induction of Phase 2 enzymes and elevation of GSH, human hepatoma HepG2 cells that were stably transfected with a reporter construct under regulatory control of EpRE were examined for the correlation of intracellular AUCs of ITCs with the induction of the reporter gene product.
Materials and methods

Chemicals
Allyl-ITC, benzyl-ITC and phenethyl-ITC were purchased from Aldrich (Milwaukee, WI) and sulforaphane (SF) was from LKT (St Paul, MN). (17) . Briefly, for the EpRE-TK-GFP construct, four concatamerized 41 base pair (bp) EpREs were linked to a 123 bp thymidine kinase (TK) promoter and the entire fragment was cloned into the multiple cloning site of pEGFP (green fluorescent protein expression vector). For the TK-GFP construct, the EpRE sequences were excluded. HepG2 cells were cultured in DMEM with high glucose and glutamine (Life Technologies) containing 10% FBS. All cells were grown on 10 cm plates at 37°C in a humidified 5% CO 2 incubator.
Cell culture
Measurement of intracellular accumulation of ITCs in PE and HepG2 cells
Intracellular accumulation of ITCs was measured by the cyclocondensation assay (reaction with 1,2-benzenedithiol) which detects both free ITCs and their dithiocarbamate (DTC) derivatives. Thus, the intracellular accumulation levels of ITCs reported in this paper refer to the total levels of both ITCs and dithiocarbamates formed in cells. The procedures for cell exposure to ITCs, cell harvest, preparation of cell lysates and quantitation of ITC/DTC in cell lysates by the cyclocondensation assay have been previously described (10) . Briefly, 1ϫ10 6 cells were cultured with 10 ml medium on each 10 cm plate for 3-5 days so that the cells were nearly confluent. The medium was then replaced with the same volume of fresh medium containing 5 µM ITC in 10 µl acetonitrile and incubation was continued. At 0.5, 1, 2, 3, 6, 12 and 24 h, cells in two plates were rapidly trypsinized and harvested. HepG2 cells were detached by incubation of each plate with 1 ml 0.05% trypsin for 5 min and 9 ml medium were then added to each plate. PE cells were more resistant to trypsin treatment. Consequently, 0.2 ml 10% trypsin was added to the existing medium (final concentration 0.2%) 25 min before the harvest time to detach cells. We found that trypsin did not interfere with ITC uptake. Each 10 ml suspension was then quickly layered on top of 2 ml 1:1 (v/v) dibutyl phthalate/diisononyl phthalate in a 15 ml conical tube and centrifuged at 3000 r.p.m. and 4°C for 2 min. Each cell pellet was resuspended in 200 µl distilled water and stored at -70°C. The cells were sonicated before use and the total content of ITC/DTC in each lysate was determined by the HPLC-based cyclocondensation assay (10, 18) . The ITC/DTC content in lysates was adjusted by protein levels in the lysates, which were measured by the BCA assay (19) .
The intracellular accumulation levels of each ITC at all time points were then determined by an interactive computer program (LAGRAN method) to calculate the AUC (20) . Determination of cellular GSH levels, QR and GST activities, and GFP levels after exposure to ITCs Cell pellets were prepared as described above. In experiments designed to assess the effects of multiple dosing of ITCs, the medium was replaced each time with fresh medium containing 5 µM ITC as indicated.
Cellular GSH levels were determined by the glutathione reductase-coupled 5,5Ј-dithiobis 2-nitrobenzoic acid (DTNB) assay in 96-well microtiter plates (21) . Briefly, each cell pellet was sonicated in~200 µl Dulbecco's phosphatebuffered saline (DPBS) (PE cells) or lysed in 200 µl 0.08% digitonin solution (HepG2 cells, see QR assay below for details). GSH contents were very similar in lysates prepared by the two methods. Lysates (20 µl) were mixed with 80 µl ice-cold 2.5% metaphosphoric acid (MPA) on ice for 20 min and centrifuged at 14 000 r.p.m. for 2 min at 4°C. The supernatant fraction was diluted 20-fold with 100 mM sodium phosphate plus 5 mM EDTA (assay buffer), pH 7.5. In each well, 50 µl each diluted sample was mixed with 50 µl 1.26 mM DTNB in assay buffer and 50 µl 2.5 U/ml glutathione reductase (bakers yeast; Sigma, St Louis, MO) in assay buffer. After 5 min incubation at room temperature, 50 µl 0.72 mM NADPH in assay buffer were added to each well and the initial reaction rates were measured at 405 nm by a Spectra Max Plus microtiter plate reader (Molecular Devices, Sunnyvale, CA). Several concentrations of pure GSH were also assayed on the same plate to establish a calibration curve for calculation of GSH content in the samples.
To measure cytosolic QR activity, cell lysates were prepared by mixing each cell pellet with~200 µl digitonin solution (0.8 g/l digitonin in 2 mM EDTA, pH 7.8) and incubating at 37°C for 10 min, followed by gentle shaking for 10 min at room temperature and centrifugation at 14 000 r.p.m. and 4°C for 3 min. The QR activity in the supernatant fractions was determined in a 300 µl assay in 96-well microtiter plates (5, 22) . Each fraction was diluted with 10 mM Tris-HCl buffer, pH 7.4 and 50 µl aliquots of the diluted solution were added to each well together with 50 µl phosphate buffer (5 mM potassium phosphate, pH 7.4 and 0.5% dimethyl sulfoxide). In order to exclude nonspecific enzyme activity (dicumarol non-inhibitable), 50 µl phosphate buffer containing 0.3 mM dicumarol were added to parallel wells in place of the regular buffer. Then to each well was added 200 µl assay solution containing 25 mM Tris-HCl pH 7.4, 0.5% bovine serum albumin, 0.025% Tween 20, 5 µM FAD, 30 µM NADP, 1 µM glucose-6-phosphate, 2 U/ml glucose-6-phosphate dehydrogenase (bakers yeast; Sigma), 0.3 mg/ml 3-(4,5-dimethylthi- Approximately 5ϫ10 6 cells grown in monolayers on each 10 cm plate were incubated with 10 ml medium containing 5 µM ITC for 24 h. Cells were then harvested by trypsin treatment and GSH content was measured in cell lysates prepared by sonication. Each value is the mean of six determinations (standard errors are generally Ͻ1.3% of the mean). a Numbers in parentheses are the ratio of specific GSH levels (treated cells/ control cells).
azol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) and 25 µM menadione. The reaction rates were immediately measured at 610 nm for 5 min at room temperature by the microtiter plate reader. For each sample, the specific activity of QR was derived by subtracting the initial reaction rates in wells containing no dicumarol from those in wells containing dicumarol. Cytosolic GST activity was assayed with 1-chloro-2,4-dinitrobenzene (CDNB) as substrate (23) either in a 1 or 0.3 ml volume. The 1 ml assay was slightly modified from the published method and consisted of 100 mM sodium phosphate buffer (pH 7.4), 1 mM GSH, 1 mM CDNB, 2% (v/v) ethanol (CDNB was originally dissolved in ethanol) and 10 µl sample solution. Each cell pellet prepared as above was suspended in 200 µl 10 mM Tris-HCl (pH 7.4), sonicated for complete cell lysis and centrifuged at 14 000 r.p.m. for 3 min at 4°C. The supernatant fractions were used for the assay and the initial reaction rate was measured at 340 nm. We later found that GST activity could be more conveniently determined in microtiter plates by lysing the cells with digitonin (as described for QR) and that this procedure also resulted in higher recovery of GST activity than the sonication method. Thus, cell lysates were prepared as described for the QR assay. Each 0.3 ml assay contained 100 mM potassium phosphate (pH 6.5), 1 mM GSH, 1 mM CDNB, 2% (v/v) ethanol and 20 µl sample solution. The initial reaction rates were measured at 340 nm by the microtiter plate reader.
Cellular GFP content was determined by fluorescence emitted in samples derived from HepG2/EpRE-TK-GFP and HepG2/TK-GFP cells. Cell lysates were prepared by digitonin treatment as described above and the lysates were centrifuged at 14 000 r.p.m. for 3 min at 4°C. Supernatant fractions (usually 10 µl) were diluted to 2 ml with DPBS and the fluorescence intensity of each solution was read with a luminescence spectrometer (LS50; Perkin Elmer, Norwalk, CT) at excitation/emission wavelengths 485/530 nm (17) .
Results
GSH elevation by ITCs in different cell lines
In order to select a suitable cell line to examine whether intracellular ITC accumulation levels (AUCs) play a role in Phase 2 enzyme induction and GSH elevation, PE, MCF-7 and Hepa 1c1c7 cells were screened for the degree of GSH elevation by known Phase 2 enzyme inducers: allyl-ITC, benzyl-ITC and SF. Cellular GSH contents were measured after cells were incubated with each ITC at 5 µM for 24 h. As expected, basal intracellular GSH levels differed widely with cell types, but all these cell lines showed elevated GSH levels after ITC exposure. Table I shows that PE cells were the most responsive, with intracellular GSH increasing from 1.8-fold with allyl-ITC to 4.3-fold with SF. Smaller elevations were observed with MCF-7 cells and Hepa 1c1c7 cells. In PE cells the degree of GSH elevation differed considerably with each ITC inducer, suggesting that this cell line would be suitable for evaluating the relation between the intracellular AUC of ITCs and the degree of enzyme induction. We also examined the effect of ITC exposure time on elevation of GSH levels by incubating cells with each ITC at 5 µM for 12, 24, 48 or 72 h. We found that levels of GSH were highest after incubation with ITCs for 24 h (data not shown). Therefore, for subsequent studies, PE cells were routinely incubated with each ITC for 24 h, unless otherwise stated.
Correlation of intracellular accumulation levels (AUCs) of ITCs with elevation of GSH and induction of QR and GST in PE cells
To determine whether the AUCs of intracellular accumulation of ITCs correlated with their ability to raise levels of GSH, and GST and QR activity, we incubated PE cells in monolayers with allyl-ITC, benzyl-ITC and SF, as well as phenethyl-ITC which is also a known Phase 2 enzyme inducer, each at 5 µM for 0.5, 1, 2, 3, 6, 12 and 24 h. At each time point the intracellular accumulation of each ITC was measured by the cyclocondensation assay as described above. The assay measures both free ITCs and their DTC derivatives in cell lysates, and the AUCs were calculated based on these measurements (our earlier study in Hepa 1c1c7 cells had shown that ITCs were accumulated mainly as DTCs derived from conjugation with GSH and that the DTC formed may be metabolized further) (11) . We found that, similar to prior studies in Hepa 1c1c7 cells, (i) uptake was very rapid for all compounds; intracellular levels reached a peak around 0.5-1 h after initial exposure; (ii) the peak levels differed significantly among ITCs and (iii) the rates of decrease in intracellular ITC levels also differed considerably. Whereas intracellular SF levels decreased relatively slowly (half-life about 22 h) after the peak level was reached, levels of the other three ITCs decreased by 50% within 3-6 h (Figure 1, Fig. 2 . Induction of glutathione transferase and quinone reductase and elevation of glutathione in PE cells by isothiocyanates. PE cells were grown on 10 cm plates with 10 ml medium for 4 days to reach~5ϫ10 6 cells per plate. Cells on each plate were then incubated with 10 ml fresh medium containing 5 µM allyl-ITC, benzyl-ITC, phenethyl-ITC or SF for 24 h. Cells were harvested by trypsin treatment and the activities of both GST (u) and QR (j), and GSH levels ( ) were determined. GST activity was determined in a 1 ml assay and cell lysates were prepared by sonication. The ratios were calculated from values each of which was a mean of three, four or six measurements (standard errors are generally Ͻthan 4% of the means). The specific activities of GST and QR in control cells were 11.92 and 11.86 nmol/min/mg, respectively, and the GSH level was 9.4 nmol/mg protein.
top; note also the different levels in HepG2/EpRE-TK-GFP cells in Figure 1 , bottom, which are described later).
Cellular GSH content and QR and GST activities were measured at the end of the 24 h exposure. As shown in Figure 2 , all four ITCs elevated cellular GSH level and QR activity, ranging from 1.8-to 5.4-fold, with SF the most potent inducer. GST was less responsive to ITCs and again SF was the best inducer. We then calculated the AUC of the intracellular accumulation levels within 24 h and compared these values with the ratios (treated over control) of specific enzyme activities and GSH levels. Figure 3 shows that these AUCs correlated closely with the increases in GSH, QR and GST (correlation coefficients of linear regression range from 0.82 to 0.94), even though the increases by each ITC differed widely. In contrast, there was no clear correlation between the increases in GSH, QR and GST and the peak ITC accumulation levels. For example, the peak intracellular benzyl-ITC level was much higher than that of SF, but the latter compound was a much more potent inducer. Similarly, the peak accumulation of phenethyl-ITC was only slightly lower than that of SF, but the former compound was a much weaker inducer.
Effect of multiple dosing with ITCs on QR and GST activities in PE cells
On the basis of the above experiments showing that induction of Phase 2 enzymes and elevation of GSH closely correlated with the degree of accumulation of ITCs, we questioned whether increasing the intracellular accumulation of ITCs by multiple dosing would enhance induction. Accordingly, PE cells were incubated with either 5 µM phenethyl-ITC or SF for 24 h, but the medium was replaced with fresh medium containing the same concentration of ITC every 8 h. As shown in Figure 2 , phenethyl-ITC was a much weaker inducer than was SF, but Table II shows that treatment of the cells three times with fresh medium containing 5 µM phenethyl-ITC substantially increased induction of QR and GST compared with one treatment. In contrast, treatment with SF three times did not increase induction, suggesting that both GST and QR (20) . The specific GST and QR activities, and GSH levels were determined in PE cells treated with or without 5 µM ITC for 24 h and the ratios of the specific enzyme activities and GSH levels (treated cells/control cells) were calculated (see Figure 2) . The intracellular AUCs of ITCs were then plotted against the ratios of specific enzyme activities and GSH levels: a, allyl-ITC; b, phenethyl-ITC; c, benzyl-ITC; d, SF. activity may have been maximally induced by the single SF incubation for 24 h. This notion is supported by the finding that increases in GST and QR activities in cells treated three times with phenethyl-ITC were very similar to those in cells treated with SF either once or three times. Accordingly, we calculated that the AUC of intracellular accumulation of an ITC required for maximal elevation of GSH, GST and QR in PE cells within 24 h is~260 (nmol/mg)ϫh. The effect of multiple dosing on intracellular GSH content was not clearcut, because replacement with medium alone also resulted in a significant increase in intracellular GSH content, possibly due to cystine or cysteine present in the medium.
Correlation of cellular accumulation levels (AUCs) of ITCs with both GFP and GSH elevation levels in HepG2/EpRE-TK-GFP cells and HepG2/TK-GFP cells
It is now widely recognized that Phase 2 enzyme induction and GSH elevation are mediated by a small regulatory DNA element, namely ARE or EpRE, which resides in the upstream region of many Phase 2 enzyme genes. In order to determine whether the intracellular AUC-dependent induction of Phase 2 enzymes by ITCs is mediated by EpRE/ARE, we examined induction of GFP in both HepG2/EpRE-TK-GFP and HepG2/ TK-GFP cells. The GFP gene was stably introduced into HepG2 cells through an expression vector with (the former cells) or without (the latter cells) four concatamarized EpREs in the upstream region of the gene by Zhu and Fahl (17) . They have shown that incubation of HepG2/EpRE-TK-GFP cells with various known Phase 2 enzyme inducers including ITC resulted in significant induction of GFP, whereas little increase .86 nmol/min/mg protein, respectively. Note that the specific GST activities in control cells in the two experiments were different. The former cells were lysed by digitonin, whereas the latter cells were lysed by sonication which results in partial loss of the enzyme activity. The sonication procedure was initially used in our study, but was changed to digitonin treatment when the latter procedure was found to yield higher enzyme activities in cell lysates.
of GFP level was detected in HepG2/TK-GFP cells, indicating that the transcriptional activation of GFP gene is strictly under EpRE control. Incubation of HepG2/EpRE-TK-GFP cells with allyl-ITC, benzyl-ITC, phenethyl-ITC or SF at 5 µM for 24 h resulted in 1.83-, 1.70-, 1.36-and 2.49-fold increases in GFP levels, respectively, whereas there were no detectable changes in GFP levels when HepG2/TK-GFP cells were incubated with the same ITCs under the same conditions (Table III) , indicating again that the EpREs were essential in transcriptional activation of GFP by ITCs.
We then measured the intracellular AUC of each ITC at 5 µM in HepG2/EpRE-TK-GFP cells after incubation for different times up to 24 h, as described in Materials and methods. The accumulation kinetics of the four ITCs differed significantly from each other (Figure 1, bottom) . When the AUCs of intracellular accumulations of each ITC within 24 h were compared with induction of GFP (-fold increases), however, a very close correlation was seen (correlation coefficient of linear regression 0.98) (Figure 4 ), indicating that GFP induction is dependent on overall intracellular AUC of ITCs and such dependence is mediated by EpRE. This finding therefore suggests that the intracellular AUC-dependent induction of Phase 2 enzyme and elevation of GSH in PE cells and other cells is likely mediated by EpRE/ARE. Moreover, although induction of GST and QR by the ITCs in HepG2/ EpRE-TK-GFP cells did not reach significance, intracellular GSH levels were raised by as much as 2.2-fold and these levels again closely correlated with the intracellular AUCs (correlation coefficient of linear regression 0.95) (Figure 4 ).
Of note, the level of accumulation of ITCs in HepG2/EpRE- The intracellular AUC of each ITC in HepG2/EpRE-TK-GFP cells (exposed to 5 µM ITC for 24 h) was calculated from the data shown in Figure 1 (bottom) by the LAGRAN computer program (20) . The specific GFP and GSH levels in cells treated with or without 5 µM ITC for 24 h were determined and the ratios of the specific GSH and GFP levels (treated cells/control cells) were calculated (see Table III ). The intracellular AUCs of ITCs were then plotted against the ratios of the specific GFP and GSH levels: a, phenethyl-ITC; b, benzyl-ITC; c, allyl-ITC; d, SF.
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TK-GFP cells were lower than those found in PE cells and the peak levels were reached later, 0.5-3 h after the start of exposure compared with 0.5-1 h in PE cells. Moreover, the intracellular AUC of allyl-ITC was higher than those of benzyl-ITC and phenethyl-ITC in HepG2/EpRE-TK-GFP cells, in contrast to PE cells where intracellular AUC of allyl-ITC was lower than those of benzyl-ITC and phenethyl-ITC in PE cells.
Effect of multiple dosing of ITCs on elevation of both GFP and GSH in HepG2/EpRE-TK-GFP cells
Since multiple dosing of phenethyl-ITC enhanced the elevation of both GST and QR in PE cells, whereas multiple dosing with SF did not, we examined the effect of three doses of these ITCs on elevation of GFP and GSH in HepG2/EpRE-TK-GFP cells. Thus, the cell monolayers were incubated with either 5 µM phenethyl-ITC or SF and the medium was replaced with fresh medium containing the same ITC at the same concentration every 8 h for a total of 24 h (three times). As shown in Table III The correlation between the inducer activity of ITCs and their overall intracellular accumulation levels, AUCs, was further illustrated by phenethyl-ITC in a multiple dosing experiment. Phenethyl-ITC accumulated at a much lower level than SF, and the accumulated compound was also removed more rapidly than SF in both PE and HepG2/EpRE-TK-GFP cells. The induction of GST and QR in PE cells and GSH in HepG2/EpRE-TK-GFP cells by phenethyl-ITC was very low when the cells were incubated with 5 µM for 24 h. Induction was dramatically increased, with levels very close to those induced by SF, when the cells were incubated with fresh medium containing 5 µM phenethyl-ITC three times during the 24 h period. Similar replacement with SF, however, did not result in enhanced induction. It seems likely, therefore, that maximal induction of GST, QR and GSH might have been attained when the cells were treated with 5 µM SF for 24 h. Sulforaphane was previously found to be the most potent inducer among several dozen of ITCs tested (3, 5) .
The intracellular accumulation levels of ITCs in the present study were measured by the cyclocondensation assay, which detects both free ITCs and DTCs that result from conjugation of ITCs with sulfhydryl agents such as GSH. Hence the accumulated ITCs are likely to be a mixture of several chemical entities. As previously pointed out, however, both free ITCs and their DTC derivatives may be the ultimate inducer forms (12) . Inducer activities of nearly all Phase 2 enzyme inducers are related to their chemical reactivity with sulfhydryl groups (24) (25) (26) . It is known that both ITCs and their DTC derivatives can undergo reaction with sulfhydryl groups.
Whatever is the ultimate inducer form, much evidence indicates that transcriptional activation of Phase 2 enzymes by inducers are regulated by the ARE/EpRE located on the upstream region of the cognate genes and that such a mechanism operates across cell types (13, 16, 27) . In the present study, by utilizing cells that were stably transfected with an EpRE driven reporter construct (EpRE-TK-GFP), we showed that the intracellular AUC-dependent elevation of Phase 2 enzymes and GSH by ITCs may be mediated by EpRE/ARE. This, together with the findings in PE cells and our previous finding in Hepa 1c1c7 cells (10) , strongly suggests that the intracellular AUC-dependent induction of Phase 2 enzymes and elevation of GSH by ITCs is a common mechanism shared by a variety of cell types. We therefore propose that the overall intracellular accumulation (AUCs) levels of ITCs may serve as useful markers of their activity in elevating cellular detoxification capacity. If confirmed in vivo, these markers may provide valuable guidance in developing ITCs as cancer chemoprotective agents in humans. In fact, Conaway et al. (28) recently reported that higher levels of phenylhexyl-ITC in target organs in F344 rats, compared with that of phenethyl-ITC, correlated with its greater potency as a cancer chemopreventive agent. In conclusion, it appears that understanding of the intracellular ITC/DTC accumulation kinetics, as measured by the AUCs, is the key to developing rational dosing regimens for chemoprotection of humans by induction of Phase 2 enzymes and elevation of GSH.
